These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22051689)

  • 1. Regarding cancer predisposition detected by CHG arrays.
    Collins DL; Schimke RN
    Genet Med; 2011 Nov; 13(11):982; author reply 982-3. PubMed ID: 22051689
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of genotype-first diagnosis: the detection of microdeletion and microduplication syndromes with cancer predisposition by aCGH.
    Adams SA; Coppinger J; Saitta SC; Stroud T; Kandamurugu M; Fan Z; Ballif BC; Shaffer LG; Bejjani BA
    Genet Med; 2009 May; 11(5):314-22. PubMed ID: 19365269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disease susceptibility genes and genome structural abnormalities associated with developmental disabilities].
    Yamamoto T
    No To Hattatsu; 2014 Mar; 46(2):131-5. PubMed ID: 24738191
    [No Abstract]   [Full Text] [Related]  

  • 4. Interpretation of array comparative genome hybridization data: a major challenge.
    Gijsbers AC; Schoumans J; Ruivenkamp CA
    Cytogenet Genome Res; 2011; 135(3-4):222-7. PubMed ID: 22086107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 16p13.11 duplication is a risk factor for a wide spectrum of neuropsychiatric disorders.
    Ramalingam A; Zhou XG; Fiedler SD; Brawner SJ; Joyce JM; Liu HY; Yu S
    J Hum Genet; 2011 Jul; 56(7):541-4. PubMed ID: 21614007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recurrent 1.71 Mb genomic imbalance at 2q13 increases the risk of developmental delay and dysmorphism.
    Yu HE; Hawash K; Picker J; Stoler J; Urion D; Wu BL; Shen Y
    Clin Genet; 2012 Mar; 81(3):257-64. PubMed ID: 21255006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an X-linked deletion syndrome through comparative genomic hybridization microarray.
    Rush ET; Schaefer GB
    Semin Pediatr Neurol; 2010 Mar; 17(1):51-3. PubMed ID: 20434696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural genome variations in individuals with childhood cancer and tumour predisposition syndromes.
    Hopman S; Merks J; Eussen H; Douben H; Snijder S; Hennekam R; de Klein A; Caron H
    Eur J Cancer; 2013 Jun; 49(9):2170-8. PubMed ID: 23473611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 5.3-Mb duplication of 9p12 --> p13.1 characterized by array CGH in a female infant with developmental delay.
    Chen CP; Lin SP; Chern SR; Tsai FJ; Lee CC; Pan CW; Wu PC; Wang W
    Genet Couns; 2010; 21(4):457-60. PubMed ID: 21290975
    [No Abstract]   [Full Text] [Related]  

  • 10. Array-CGH detection of a de novo 2.8 Mb deletion in 2q24.2-->q24.3 in a girl with autistic features and developmental delay.
    Chen CP; Lin SP; Chern SR; Chen YJ; Tsai FJ; Wu PC; Wang W
    Eur J Med Genet; 2010; 53(4):217-20. PubMed ID: 20346423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 15q11.2 proximal imbalances associated with a diverse array of neuropsychiatric disorders and mild dysmorphic features.
    Abdelmoity AT; LePichon JB; Nyp SS; Soden SE; Daniel CA; Yu S
    J Dev Behav Pediatr; 2012 Sep; 33(7):570-6. PubMed ID: 22922608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of microarray-based molecular cytogenetics: an emerging new era of genomic medicine.
    Li MM; Andersson HC
    J Pediatr; 2009 Sep; 155(3):311-7. PubMed ID: 19732576
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation.
    Stankiewicz P; Beaudet AL
    Curr Opin Genet Dev; 2007 Jun; 17(3):182-92. PubMed ID: 17467974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TASP1 is deleted in an infant with developmental delay, microcephaly, distinctive facial features, and multiple congenital anomalies.
    Suleiman J; Mundt M; Sampath S; El-Hattab AW
    Clin Genet; 2018 Jul; 94(1):170-173. PubMed ID: 29633245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical utility of molecular karyotyping using high-resolution array-comparative genomic hybridization.
    Tzetis M; Kitsiou-Tzeli S; Frysira H; Xaidara A; Kanavakis E
    Expert Rev Mol Diagn; 2012 Jun; 12(5):449-57. PubMed ID: 22702362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duplication of the Wolf-Hirschhorn syndrome critical region causes neurodevelopmental delay.
    Hannes F; Drozniewska M; Vermeesch JR; Haus O
    Eur J Med Genet; 2010; 53(3):136-40. PubMed ID: 20197130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Molecular Delineation of a Novel De Novo 4q28.3-31.21 Interstitial Deletion in a Patient with Developmental Delay.
    Rim JH; Kim SW; Han SH; Yoo J
    Yonsei Med J; 2015 Nov; 56(6):1742-4. PubMed ID: 26446663
    [No Abstract]   [Full Text] [Related]  

  • 18. [Congenital malformations in pediatric tumors].
    Amiel J; Lacombe D; Attié T; Munnich A; Lyonnet S
    Arch Pediatr; 1998; 5 Suppl 2():88s-89s. PubMed ID: 9759225
    [No Abstract]   [Full Text] [Related]  

  • 19. A patient with 9q subtelomeric deletion syndrome with additional findings.
    Tug E; Cavdarli B; Karaoguz MY; Percin FE
    Genet Couns; 2012; 23(4):465-71. PubMed ID: 23431745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel 1.13 Mb Interstitial Duplication at 19q13.32 Causing Developmental Delay and Microcephaly in a Pediatric Patient: the First Asian Case Reports.
    Rim JH; Kim JA; Yoo J
    Yonsei Med J; 2017 Nov; 58(6):1241-1244. PubMed ID: 29047251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.